S100A14 and neoplasm: We hypothesize that S100A14 may play a role in shaping the anti-tumor immune microenvironment characteristic of SSL and MSI-H colorectal cancers, potentially serving as both a therapeutic target and a prognostic biomarker for predicting immunotherapy response.